Cell and gene therapy: In vivo and Ex vivo in comparison
Gene therapy is a technique that modifies a person’s genes to treat or cure disease. Ex Vivo and In Vivo are two different approaches you will learn about in this article!
Gene-modified Cell Therapies enable unique approaches to novel treatments. After collection of cells from patients the genes are edited ex vivo to boost their function and persistence before they are re-administered into the patients body. This includes CAR-T (chimeric antigen receptor) therapies.
The manufacturing process for gene-modified cell therapies comes along with challenges during fluid and cold chain management. It is of utmost importance to rely on safe cold chain solutions and handling processes for both drug products and vector products.
Discover Single Use Support's range of solutions for reliable cold chain management, automated drug substance dispensing and filling and logistical handling for cell therapy and vector product developers and manufacturers.
Freezing and thawing at controlled freezing rate is essential to achieve minimized cell damage and maintained cell viability after thawing gene-modified cell therapies. Furthermore, automated liquid transfer, aliquotation, storage and shipment solutions facilitates safe and standardized handling of personalized therapies at different scales and accelerate turnaround times until readminstration.
Primary Packaging
Feed Source for Aliquotation
Automated Aliquotation
Robust Protection
Controlled Rate Freezing
Cold Storage
Shipping
Sterile aliquoting into single-use bags and freezing for cryopreservation of cells pose challenges for laboratories and manufacturers. Download the App Note to learn more about the implications and approaches to address these challenges.